| __timestamp | Amneal Pharmaceuticals, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 5078000000 |
| Thursday, January 1, 2015 | 109679000 | 4717000000 |
| Friday, January 1, 2016 | 118757000 | 5096000000 |
| Sunday, January 1, 2017 | 109046000 | 4986000000 |
| Monday, January 1, 2018 | 230435000 | 4214000000 |
| Tuesday, January 1, 2019 | 289598000 | 3806000000 |
| Wednesday, January 1, 2020 | 326727000 | 3671000000 |
| Friday, January 1, 2021 | 365504000 | 3528000000 |
| Saturday, January 1, 2022 | 399700000 | 3445000000 |
| Sunday, January 1, 2023 | 429675000 | 3498000000 |
| Monday, January 1, 2024 | 3702000000 |
Unleashing the power of data
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. This analysis compares the SG&A expenses of Teva Pharmaceutical Industries Limited and Amneal Pharmaceuticals, Inc. from 2014 to 2023.
Teva, a global leader in generic medicines, has seen a significant reduction in its SG&A expenses, dropping by approximately 31% from 2014 to 2023. This decline reflects Teva's strategic cost-cutting measures and operational efficiencies. In contrast, Amneal, a relatively newer player, has experienced a substantial increase in its SG&A expenses, growing by over 400% during the same period. This rise indicates Amneal's aggressive expansion and investment in market penetration.
Understanding these trends provides valuable insights into the strategic priorities and financial health of these pharmaceutical giants, offering a glimpse into their future trajectories.
Cost Management Insights: SG&A Expenses for Amgen Inc. and Teva Pharmaceutical Industries Limited
Breaking Down SG&A Expenses: argenx SE vs Teva Pharmaceutical Industries Limited
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and CRISPR Therapeutics AG
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Teva Pharmaceutical Industries Limited or Supernus Pharmaceuticals, Inc.
Biogen Inc. and Amneal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Insmed Incorporated or Amneal Pharmaceuticals, Inc.
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Viking Therapeutics, Inc. Trends and Insights
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of Amneal Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Amneal Pharmaceuticals, Inc. or Iovance Biotherapeutics, Inc.